TESTOSTERONE
- Product NDC
- 62332-488
- 11-digit product format
- 623320488
- Labeler code
- 62332
- Product ID
- 62332-488_5ce13b01-78d1-49fa-80c9-6e54d0774e14
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TESTOSTERONE
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA212882
- Marketing category
- ANDA
- Marketing start
- 2021-12-08
- Substance
- TESTOSTERONE
- Active strength
- 30 mg/1.5mL
- Pharmacologic classes
- Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212882-001 | TESTOSTERONE | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | AT | 2021-06-14 | 782e0a99824c… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212882-001 | TESTOSTERONE | 30MG/1.5ML ACTUATION | SOLUTION, METERED / TRANSDERMAL | 2021-06-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2021-12-28 21:50 UTC | 2021-12 | A212882-001 | AT | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TESTOSTERONE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TESTOSTERONE | 30 mg/1.5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3XMK78S47O | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1599949 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e39289aa-681c-47ec-9461-52e7f17e5d71 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2db4fc38-a116-b0ab-3dae-57df54e5f212 | Product name | 2 | 20250121 |
| 386d1b2a-e9b7-0c83-111f-2a77b92895b3 | Product name | 5 | 20240422 |
| 7d55b53c-798b-47ae-992b-3921493a8303 | Product name | 1 | 20230322 |
| 8d753fd6-75b2-4f12-bcbf-339392960afa | Product name | 1 | 20230303 |
| 4fbda828-a5be-46fe-83ec-a88da4359919 | Product name | 1 | 20230104 |
| 93cc9bee-8bdc-273d-ec7f-c2c52535317a | Product name | 7 | 20210902 |
| a6389cd1-36d1-4b5c-9934-1139bee93605 | Product name | 5 | 20210601 |
| f4f0889f-ee8b-471f-9a37-02a035280637 | Product name | 1 | 20200122 |
| 09e1afd3-f431-4380-82c5-438884c25615 | Product name | 1 | 20190111 |
| a6389cd1-36d1-4b5c-9934-1139bee93605 | Product name | 3 | 20171212 |
| 502efed8-01a5-ef6a-61c6-fe8302b6e26b | Product name | 2 | 20171113 |
| 8b700cfd-17dd-41a2-90f5-a80ae8a989a2 | Product name | 1 | 20171113 |
| 9ce0e503-4ae7-2c6a-39ae-85285c29db68 | Product name | 2 | 20171113 |
| 96bdf4b3-71cd-433d-9723-89e50f852992 | Product name | 1 | 20150810 |
| ed2e617f-f28a-1df1-f9fc-c79702f31271 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62332-488-11 | TESTOSTERONE | 110 mL in 1 BOTTLE, WITH APPLICATOR | SOLUTION | 110 | 9 | |
| 62332-488-11 | TESTOSTERONE | 1 in 1 CARTON | SOLUTION | 1 | 9 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TESTOSTERONE | TESTOSTERONE | Alembic Pharmaceuticals Inc. | e39289aa-681c-47ec-9461-52e7f17e5d71 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 212882 ANDA212882 62332-488 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1599949 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | e39289aa-681c-47ec-9461-52e7f17e5d71 | 9 |
| 1599949 | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | e39289aa-681c-47ec-9461-52e7f17e5d71 | 9 |
| 1599949 | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | e39289aa-681c-47ec-9461-52e7f17e5d71 | 9 |
| 1599949 | testosterone (as testosterone propionate) 2 % Topical Solution | SY | e39289aa-681c-47ec-9461-52e7f17e5d71 | 9 |
| 1599949 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | e39289aa-681c-47ec-9461-52e7f17e5d71 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 62332-488-11 | 62332048811 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR | 2021-12-08 | 0000-00-00 | No | No | Current |